Clinical Trial Update: Anti-malaria MAb in Kenyan Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an anti-malaria monoclonal antibody in Kenyan children has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Infection

Drugs mentioned

• Anti-malaria monoclonal antibody

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection, Malaria | Phase 2 | Status: COMPLETED | Results posted: 2025-10-16